# A Study of HRS-7535 Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequately Controlled With Diet and Exercise

> **NCT06672172** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Shandong Suncadia Medicine Co., Ltd.** · enrollment: 284 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** HRS-7535 tablet
- **DRUG:** HRS-7535 tablet
- **DRUG:** HRS-7535 tablet
- **DRUG:** HRS-7535 placebo tablet

## Key facts

- **NCT ID:** NCT06672172
- **Lead sponsor:** Shandong Suncadia Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-09-25
- **Primary completion:** 2025-11-15
- **Final completion:** 2026-04-21
- **Target enrollment:** 284 (ACTUAL)
- **Last updated:** 2025-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06672172

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06672172, "A Study of HRS-7535 Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequately Controlled With Diet and Exercise". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT06672172. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*